Pay in this profession is unusually stage-dependent even by academic standards: a PhD student is paid a stipend well below minimum-wage-equivalent in some countries, while a senior industry scientist or biotech executive in the same field can earn many multiples more, often within the same city.
It is also sharply divided by sector as much as by country: university and government research salaries tend to lag well behind private pharmaceutical and biotech industry pay for comparable seniority almost everywhere, which is part of why so many biology PhDs eventually move from academia into industry.
The pay ladder
US, typical annual PhD stipend range, 2024; many countries pay considerably less, some considerably more.
US, NIH-recommended minimum postdoctoral stipend range, 2024; typical starting postdoc pay in academic biology.
US, typical entry-level salary for a PhD-holding scientist in industry or an assistant professor, 2024 estimates.
US, typical senior academic or established industry scientist salary, 2024 estimates.
US, typical total compensation for a chief scientific officer or distinguished scientist at a biotech or pharmaceutical company, 2024 estimates.
What it pays around the world
United States
Typical range for PhD-level biologists across academia and industry, BLS and industry salary surveys, 2023–24.
Switzerland
Typical PhD-level research scientist salary in Basel's dense pharmaceutical and biotech cluster, 2024 estimates.
Germany
Typical postdoctoral or early-career scientist salary at a public research institute, 2024 estimates.
United Kingdom
Typical university research-scientist salary scale, UK academic pay spine, 2024–25.
Japan
Typical university or national-institute researcher salary, 2024 estimates.
India
Typical government research-institute scientist pay scale, 2024; private biotech pay can run considerably higher.
Key numbers
Who employs them
Roche
Swiss pharmaceutical and diagnostics company headquartered in Basel, and one of the world's largest employers of biological researchers.
Pfizer
US pharmaceutical company and major employer of biologists across drug discovery, vaccine development and clinical research.
National Institutes of Health (NIH)
The largest public funder and employer of biomedical research in the United States, running dozens of its own intramural research laboratories.
Max Planck Society
German basic-research organization operating dozens of specialized life-sciences institutes, among the most cited research organizations in the world.
BGI Genomics
Chinese genomics company and one of the world's largest DNA sequencing providers, a major employer of genomics researchers across Asia.
CSIRO
Australia's national science agency, employing biologists across agriculture, ecology, genomics and biosecurity research nationwide.
Where the demand is going
Demand for biology PhDs vastly outstrips the number of permanent academic research positions available: most countries' university systems train far more doctoral biologists each year than they can ever employ as professors, a structural mismatch commonly called the "postdoc bottleneck."
Industry demand tells a different story: the global biotechnology and pharmaceutical sector has grown rapidly, and genomics, synthetic biology and gene-editing companies in particular have expanded hiring well beyond what academic labs alone ever needed, absorbing a growing share of biology PhDs who leave the traditional academic track.
Demand is least secure at the postdoctoral and early-career stage, where short contracts and fierce grant competition are the norm nearly everywhere, and most secure at the senior, grant-winning end of the profession, where deep expertise takes over a decade to replace.